Skip to main content
. 2019 Apr;7(8):181. doi: 10.21037/atm.2019.03.68

Figure 2.

Figure 2

Contrast view of abdominal MRI before and after oral apatinib. (A) Abdominal MRI of the patient before treatment with apatinib, on November 2015: MRI showing the presence of multiple liver metastases. (B) Abdominal MRI of the patient after the initiation of treatment with apatinib, on April 2017: MRI showing that the multiple liver metastases had disappeared. MRI, magnetic resonance imaging.